Gerhard Schymik1, Alexander Würth2, Peter Bramlage2, Tanja Herbinger2, Martin Heimeshoff2, Lothar Pilz2, Jan S Schymik2, Rainer Wondraschek2, Tim Süselbeck2, Jan Gerhardus2, Armin Luik2, Bernd-Dieter Gonska2, Herbert Posival2, Claus Schmitt2, Holger Schröfel2. 1. From the Medical Clinic IV-Department of Cardiology, Municipal Hospital Karlsruhe, Academic Teaching Hospital of the University of Freiburg, Germany (G.S., T.H., R.W., A.L., C.S.); Medical Clinic III-Department of Cardiology, Vincentius Hospital Karlsruhe, Germany (A.W., J.G., B.-D.G.); Institut für Pharmakologie und präventive Medizin, Mahlow, Germany (P.B.); Clinic for Cardiac Surgery Karlsruhe, Germany (M.H., H.P., H.S.); Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany (L.P.); Munich Graduate School of Economics LMU Munich, Germany (J.S.S.); and Medical Clinic I-Department of Cardiology, Mannheim University, Germany (T.S.). gerhard.schymik@klinikum-karlsruhe.de. 2. From the Medical Clinic IV-Department of Cardiology, Municipal Hospital Karlsruhe, Academic Teaching Hospital of the University of Freiburg, Germany (G.S., T.H., R.W., A.L., C.S.); Medical Clinic III-Department of Cardiology, Vincentius Hospital Karlsruhe, Germany (A.W., J.G., B.-D.G.); Institut für Pharmakologie und präventive Medizin, Mahlow, Germany (P.B.); Clinic for Cardiac Surgery Karlsruhe, Germany (M.H., H.P., H.S.); Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany (L.P.); Munich Graduate School of Economics LMU Munich, Germany (J.S.S.); and Medical Clinic I-Department of Cardiology, Mannheim University, Germany (T.S.).
Abstract
BACKGROUND: Transapical transcatheter aortic valve implantation is generally perceived to be associated with increased morbidity compared with transfemoral transcatheter aortic valve implantation. We aimed to compare access-related complications and survival using propensity score matching. METHODS AND RESULTS: Prospective, single-center registry of 1000 consecutive patients undergoing transapical and transfemoral transcatheter aortic valve implantation between May 2008 and April 2012. Transapical was performed in 413 patients and transfemoral in 587 patients. Patients with transapical access were less often women and less had pulmonary hypertension. Further they had more peripheral arterial disease, coronary artery disease, carotid stenosis, and recurrent surgery and a higher logistic EuroSCORE I (24.3% ± 16.2% for transapical versus 22.2% ± 16.2% for transfemoral; P < 0.01). After building 2 propensity score-matched groups of 354 patients each with either access route (total 708 patients), baseline characteristics were comparable. In this analysis, there was no significant difference in 30 day mortality (5.9% transapical versus 8.5% transfemoral; P = 0.19), the rate of myocardial infarction (2.5% transapical versus 2.0% transfemoral; P = 0.61), stroke (2.0% transapical versus 2.3% transfemoral; P = 0.79), bleeding complications, pacemaker implantation rates, or moderate aortic insufficiency. Stage 1 renal complications were more common in transapical patients (odds ratio, 2.81; 95% confidence interval, 1.93-4.09), whereas major vascular complications were less common (odds ratio, 0.14; 95% confidence interval, 0.06-0.29). Survival probability over the long term was not statistically different (hazard ratio, 0.89; 95% confidence interval, 0.72-1.10; log-rank Test, P = 0.27). CONCLUSIONS: The data demonstrate that in an experienced multidisciplinary heart team, either access route can be performed with comparable results.
BACKGROUND: Transapical transcatheter aortic valve implantation is generally perceived to be associated with increased morbidity compared with transfemoral transcatheter aortic valve implantation. We aimed to compare access-related complications and survival using propensity score matching. METHODS AND RESULTS: Prospective, single-center registry of 1000 consecutive patients undergoing transapical and transfemoral transcatheter aortic valve implantation between May 2008 and April 2012. Transapical was performed in 413 patients and transfemoral in 587 patients. Patients with transapical access were less often women and less had pulmonary hypertension. Further they had more peripheral arterial disease, coronary artery disease, carotid stenosis, and recurrent surgery and a higher logistic EuroSCORE I (24.3% ± 16.2% for transapical versus 22.2% ± 16.2% for transfemoral; P < 0.01). After building 2 propensity score-matched groups of 354 patients each with either access route (total 708 patients), baseline characteristics were comparable. In this analysis, there was no significant difference in 30 day mortality (5.9% transapical versus 8.5% transfemoral; P = 0.19), the rate of myocardial infarction (2.5% transapical versus 2.0% transfemoral; P = 0.61), stroke (2.0% transapical versus 2.3% transfemoral; P = 0.79), bleeding complications, pacemaker implantation rates, or moderate aortic insufficiency. Stage 1 renal complications were more common in transapical patients (odds ratio, 2.81; 95% confidence interval, 1.93-4.09), whereas major vascular complications were less common (odds ratio, 0.14; 95% confidence interval, 0.06-0.29). Survival probability over the long term was not statistically different (hazard ratio, 0.89; 95% confidence interval, 0.72-1.10; log-rank Test, P = 0.27). CONCLUSIONS: The data demonstrate that in an experienced multidisciplinary heart team, either access route can be performed with comparable results.
Authors: Adam B Greenbaum; Vasilis C Babaliaros; Marcus Y Chen; Annette M Stine; Toby Rogers; William W O'Neill; Gaetano Paone; Vinod H Thourani; Kamran I Muhammad; Robert A Leonardi; Stephen Ramee; James F Troendle; Robert J Lederman Journal: J Am Coll Cardiol Date: 2016-10-29 Impact factor: 24.094
Authors: Alexander C Fanaroff; Pratik Manandhar; David R Holmes; David J Cohen; J Kevin Harrison; G Chad Hughes; Vinod H Thourani; Michael J Mack; Matthew W Sherwood; W Schuyler Jones; Sreekanth Vemulapalli Journal: Circ Cardiovasc Interv Date: 2017-10 Impact factor: 6.546
Authors: Adam Chakos; Ashley Wilson-Smith; Sameer Arora; Tom C Nguyen; Abhijeet Dhoble; Giuseppe Tarantini; Matthias Thielmann; John P Vavalle; Daniel Wendt; Tristan D Yan; David H Tian Journal: Ann Cardiothorac Surg Date: 2017-09
Authors: Toby Rogers; Kanishka Ratnayaka; William H Schenke; Merdim Sonmez; Ozgur Kocaturk; Jonathan R Mazal; Marcus Y Chen; Moshe Y Flugelman; James F Troendle; Anthony Z Faranesh; Robert J Lederman Journal: Circ Cardiovasc Interv Date: 2015-06 Impact factor: 6.546
Authors: Brandon M Jones; Amar Krishnaswamy; E Murat Tuzcu; Stephanie Mick; Wael A Jaber; Lars G Svensson; Samir R Kapadia Journal: Nat Rev Cardiol Date: 2017-07-06 Impact factor: 32.419
Authors: Giuseppe Tarantini; Paola A M Purita; Augusto D'Onofrio; Chiara Fraccaro; Anna Chiara Frigo; Gianpiero D'Amico; Luca Nai Fovino; Marta Martin; Francesco Cardaioli; Mostafa R A Badawy; Massimo Napodano; Gino Gerosa; Sabino Iliceto Journal: Ann Cardiothorac Surg Date: 2017-09